Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 5/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.44 |
| ▸ | BCHE | P06276 | 5/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | TACR2 | P21452 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16407985 | 0.98 | CYP4A11 (0.45) | CYP4A11CYP4F2ACHEPTGS2BCHE | |
| SCHEMBL2235768 | 0.95 | ACHE (0.45) | CYP4A11CYP4F2ACHEPTGS2BCHE | |
| SCHEMBL5796026 | 0.87 | PTGS2 (0.47) | CYP4A11CYP4F2ACHEPTGS2BCHE | |
| SCHEMBL5983708 | 0.84 | HTR2A (0.53) | ACHEPTGS2ALDH1A1LMNAESR1 | |
| SCHEMBL8947378 | 0.84 | CA2 (0.44) | ACHEPTGS2BCHECA2ALDH1A1 | |
| SCHEMBL3126542 | 0.80 | ACHE (0.46) | ACHEPTGS2BCHECA2 | |
| SCHEMBL4738416 | 0.80 | ACHE (0.50) | ACHEPTGS2BCHEESR1PPARA | |
| SCHEMBL20373528 | 0.79 | CYP4A11 (0.44) | CYP4A11CYP4F2ACHEPTGS2BCHE | |
| SCHEMBL6394314 | 0.77 | PTGS2 (0.57) | ACHEPTGS2BCHELMNAESR1 | |
| SCHEMBL5953374 | 0.77 | HTR2A (0.47) | CYP4A11CYP4F2ACHEPTGS2BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9278989-B2 | Sugar-derived gelator | KYUSHU UNIVERSITY (JP) | 2016-03-08 | — | — | US | disclosed |
| US-20150025157-A1 | NOVEL SUGAR-DERIVED GELATOR | INSTITUTE OF SYSTEMS, INFORMATION TECHNOLOGIES AND NANOTECHNOLOGIES (JP) | 2015-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025157-A1 | NOVEL SUGAR-DERIVED GELATOR | UGGT1, GCK, B3GAT3 | CYP4A11 1938/4885CYP4F2 2380/4885ACHE 3906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.